iCAD
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch iCAD and buy or sell other stocks, ETFs, and their options commission-free!About ICAD
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments.
CEOHoward G. Berger, MD
CEOHoward G. Berger, MD
Employees66
Employees66
HeadquartersNashua, New Hampshire
HeadquartersNashua, New Hampshire
Founded1984
Founded1984
Employees66
Employees66
ICAD Key Statistics
Market cap105.19M
Market cap105.19M
Price-Earnings ratio-19.56
Price-Earnings ratio-19.56
Dividend yield—
Dividend yield—
Average volume56.42K
Average volume56.42K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.02
52 Week high$4.02
52 Week low$1.19
52 Week low$1.19
Stock Snapshot
iCAD(ICAD) stock is priced at $3.87, giving the company a market capitalization of 105.19M. It carries a P/E multiple of -19.56.
iCAD(ICAD) stock opened on 2025-11-17 at —. The price climbed to — and dipped to —.
The iCAD(ICAD)'s current trading volume is 0, compared to an average daily volume of 56.42K.
During the past year, iCAD(ICAD) stock moved between $1.19 at its lowest and $4.02 at its peak.
During the past year, iCAD(ICAD) stock moved between $1.19 at its lowest and $4.02 at its peak.
People also own
Based on the portfolios of people who own ICAD. This list is generated using Robinhood data, and it’s not a recommendation.